# RITONAVIR
> **NDA205040** · New Drug Application · Sponsor: CIPLA LIMITED · Approved 2015-03-29
## Drug
- **FDA Application Number:** NDA205040
- **Application type:** New Drug Application
- **Brand name:** RITONAVIR
- **Generic name:** Ritonavir
- **Active ingredients:** RITONAVIR
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** CIPLA LIMITED
- **First approval:** 2015-03-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205040)
---
*AI Analytics · CC0 1.0*